Status:
COMPLETED
Functional Testing Underlying Coronary Revascularisation
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Multivessel Coronary Artery Disease
Vessel Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of this trial is to compare the clinical outcomes and cost-effectiveness of 2 therapeutic strategies, one based on coronary angiography guidance and the other based on coronary angiograp...
Eligibility Criteria
Inclusion
- age \> 18
- referred to the cardiologist for one of the following medical condition :
- ST segment elevation myocardial infarction evolving for more than 7 days after revascularization of culprit coronary artery or
- no ST elevation acute coronary syndrome with or without troponin (T or I) elevation and medically stabilized for at least 12 hours or
- stable angina (CCS I, II or III) or
- chest pain diagnosis with suspicion of CAD or with ischemia certificated by non invasive tests.
- patients with at least 2 vessel disease (≥50% stenosis on angiography) including the left anterior descending coronary artery or with single vessel disease on left main coronary artery
- Patient willing and able to provide informed, written consent
- Patient not under legal protection
- Patient benefiting from the French Health Insurance
Exclusion
- Pregnancy, childbearing, absence of effective contraception
- Previous coronary bypass surgery
- Planned associated valvular surgery
- Life expectancy \< 2 years
Key Trial Info
Start Date :
May 27 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 10 2017
Estimated Enrollment :
941 Patients enrolled
Trial Details
Trial ID
NCT01881555
Start Date
May 27 2013
End Date
June 10 2017
Last Update
September 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HOSPICES
Lyon, France, 69002